Table 1.
Characteristics of the Study Participants, Overall and by Number of Metabolic Abnormalities, in Addition to Increased WC
| Variable | Overall (n = 40) | 0 (n = 11) | 1 (n = 13) | 2–3 (n = 16) | P value for trend |
|---|---|---|---|---|---|
| Age (year) | 36.75 (6.79) | 36.70 (6.85) | 38.75 (8.39) | 35.44 (5.53) | 0.52 |
| BMI (kg/m2) | 35.14 (3.29) | 34.92 (3.47) | 34.67 (3.32) | 35.59 (3.31) | 0.55 |
| Waist circumference (cm) | 108.94 (10.40) | 102.86 (6.26) | 107.91 (13.46) | 112.31 (8.45) | 0.04 |
| SBP (mmHg) | 122.20 (13.32) | 116.00 (6.99) | 118.67 (10.42) | 128.00 (15.61) | 0.01 |
| DBP (mmHg) | 78.38 (8.38) | 76.00 (5.16) | 77.83 (7.74) | 80.06 (10.09) | 0.21 |
| Fasting glucose (mg/dL) | 91.65 (9.39) | 89.30 (7.50) | 92.83 (10.56) | 92.17 (9.78) | 0.50 |
| Total cholesterol (mg/dL) | 197.10 (29.01) | 203.40 (24.28) | 194.42 (31.60) | 195.39 (30.67) | 0.54 |
| HDL-c (mg/dL) | 48.51 (11.37) | 58.40 (11.84) | 48.84 (9.35) | 42.81 (8.57) | <0.001 |
| Median triglycerides (mg/dL) | 125.5 [98.0–180.0] | 96.5 [74.0–125.0] | 111.0 [97.0–134.5] | 176.5 [128.0–275.0] | 0.007 |
| Median AST (U/L) | 27.5 [21.0–46.5] | 27.0 [14.0–46.0] | 27.0 [21.0–47.0] | 29.0 [24.0–38.0] | 0.49 |
| Median ALT (U/L) | 48.5 [20.0–74.0] | 71.0 [68.0–74.0] | 45.0 [25.0–52.0] | 20.0 [14.0–76.0] | 0.55 |
| Median GGT (U/L) | 31.0 [26.0–63.0] | 53.5 [17.0–90.0] | 44.0 [26.0–63.0] | 31.0 [26.0–31.0] | 0.90 |
Data presented as mean (SD), median [p25–p75], or %.
ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; DBP, diastolic blood pressure; GGT, gamma glutamyl transpeptidase; HDL-c, high-density lipoprotein cholesterol; SBP, systolic blood pressure; WC, waist circumference.